| Investor Type | Firm |
| Investing | United States |
Petrichor Healthcare Capital Management is an investment firm focused on driving scientific and medical innovation. Launched in 2018, their mission is to support world-class healthcare managers and businesses with customized investment structures and support.
Their investment platform addresses a broad spectrum, from company formation through to late-stage and commercial growth opportunities, adopting a long-term and strategic approach. Petrichor demonstrates a profound in-house understanding of biopharmaceutical and medical technology products and services, providing them with the insight needed to facilitate the next generation of healthcare innovation.
Petrichor Capital Partners, a subset of the firm, provides structured investments that support the development and commercial growth of innovative biopharmaceuticals, medical technologies, and services. Their industry expertise extends beyond simple capital provision, fostering portfolio relationships that help private or public companies globally reach their growth potential. Additionally, Scion Life Sciences, as part of Petrichor, is a venture capital fund dedicated to founding and building exceptional biotechnology companies.
These companies are focused on discovering, developing, and commercializing new medicines with the potential for clinical transformation or cure, reflecting Petrichor's commitment to meaningful improvements in human health. They pride themselves on pursuing groundbreaking therapies, valuing clinical impact over incremental advancements. The firm's strategic and knowledgeable involvement in healthcare investment is aimed at creating and supporting innovative solutions that are poised to transform the healthcare landscape for the better.

